Prevalence of Antibiotic Resistance in Pediatric Malignancy Patients: A Two-Year Retrospective Study in Basra City | ||||
| The Egyptian Journal of Hospital Medicine | ||||
| Article 184, Volume 90, Issue 1, January 2023, Page 1231-1240 PDF (598.11 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/ejhm.2023.281264 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Hanan AlAulddin Abdul Jabbar  ; Ali Mohammed Hadi
| ||||
| Abstract | ||||
| Background: The most frequent side effects of chemotherapy are infections, which have substantial morbidity and mortality rates in immunocompromised patients. Aim: Toscreen the prevalence of resistance between antibiotics administered to infected patients in hematological malignancy wards. Subjects and Methods: A retrospective cross-sectional study of pediatric oncology patients was conducted from January 2021 to June 2022 at Basra children hospital. The study included 500 patients with hematological malignancies. Results: This study involved 57.8% male and 42.2% female patients. Leukemia was the most common diagnosis 59% while other solid tumors was 41%. Febrile neutropenia was only 5.8%, bacterial infection was predominant at 49.8% while the fungal infection was 9.4%, and 4.8% suspected viral infection. We found that the high percentage of antibiotics used were Cephalosporin (41.4%) and the lower percentage of antibiotics were Quinolone 0.4%. Conclusion: The most frequent form of infection was a bacterial infection, and the most frequently prescribed antibiotic for oncology patients was cephalosporin. The chest represented the most severely infected place. | ||||
| Keywords | ||||
| Neutropenia; Pediatric oncology; Bloodstream infections; Antibiotic; Basrah | ||||
|
Statistics Article View: 224 PDF Download: 423 |
||||
